{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:04:47Z","timestamp":1772910287375,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Texas Health Resources"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00125-021-05426-2","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T18:02:38Z","timestamp":1615658558000},"page":"1583-1594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-0897","authenticated-orcid":false,"given":"Matthew W.","family":"Segar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-4096","authenticated-orcid":false,"given":"Kershaw V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-1953","authenticated-orcid":false,"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa C.","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron C.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujeeb","family":"Basit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duwayne","family":"Willett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partho P.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-3836","authenticated-orcid":false,"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"issue":"5","key":"5426_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047\u20131053. https:\/\/doi.org\/10.2337\/diacare.27.5.1047","journal-title":"Diabetes Care"},{"issue":"10138","key":"5426_CR2","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","volume":"391","author":"EW Gregg","year":"2018","unstructured":"Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391(10138):2430\u20132440. https:\/\/doi.org\/10.1016\/S0140-6736(18)30314-3","journal-title":"Lancet"},{"issue":"10166","key":"5426_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I et al (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393(10166):31\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X","journal-title":"Lancet"},{"issue":"10","key":"5426_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen SL, Rorth R, Jhund PS et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol 7(10):776\u2013785. https:\/\/doi.org\/10.1016\/S2213-8587(19)30249-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"5426_CR5","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.2337\/dc19-0587","volume":"42","author":"MW Segar","year":"2019","unstructured":"Segar MW, Vaduganathan M, Patel KV et al (2019) Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: the WATCH-DM risk score. Diabetes Care 42(12):2298\u20132306. https:\/\/doi.org\/10.2337\/dc19-0587","journal-title":"Diabetes Care"},{"issue":"9","key":"5426_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s40273-018-0662-1","volume":"36","author":"H Shao","year":"2018","unstructured":"Shao H, Fonseca V, Stoecker C, Liu S, Shi L (2018) Novel risk engine for diabetes progression and mortality in USA: Building, relating, assessing, and validating outcomes (BRAVO). Pharmacoeconomics 36(9):1125\u20131134. https:\/\/doi.org\/10.1007\/s40273-018-0662-1","journal-title":"Pharmacoeconomics"},{"issue":"19","key":"5426_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.119.042685","volume":"140","author":"DD Berg","year":"2019","unstructured":"Berg DD, Wiviott SD, Scirica BM et al (2019) Heart failure risk stratification and efficacy of sodium-glucose Cotransporter-2 inhibitors in patients with type 2 diabetes mellitus. Circulation 140(19):1569\u20131577. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.042685","journal-title":"Circulation"},{"issue":"3","key":"5426_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12265-017-9739-z","volume":"10","author":"DH Katz","year":"2017","unstructured":"Katz DH, Deo RC, Aguilar FG et al (2017) Phenomapping for the identification of hypertensive patients with the myocardial substrate for heart failure with preserved ejection fraction. J Cardiovasc Transl Res 10(3):275\u2013284. https:\/\/doi.org\/10.1007\/s12265-017-9739-z","journal-title":"J Cardiovasc Transl Res"},{"key":"5426_CR9","doi-asserted-by":"publisher","first-page":"43965","DOI":"10.1038\/srep43965","volume":"7","author":"Q Guo","year":"2017","unstructured":"Guo Q, Lu X, Gao Y et al (2017) Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients. Sci Rep 7:43965. https:\/\/doi.org\/10.1038\/srep43965","journal-title":"Sci Rep"},{"issue":"3","key":"5426_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","volume":"131","author":"SJ Shah","year":"2015","unstructured":"Shah SJ, Katz DH, Selvaraj S et al (2015) Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 131(3):269\u2013279. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010637","journal-title":"Circulation"},{"issue":"1","key":"5426_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ejhf.1621","volume":"22","author":"MW Segar","year":"2019","unstructured":"Segar MW, Patel KV, Ayers C et al (2019) Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. Eur J Heart Fail 22(1):148\u2013158. https:\/\/doi.org\/10.1002\/ejhf.1621","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"5426_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ejhf.327","volume":"17","author":"DP Kao","year":"2015","unstructured":"Kao DP, Lewsey JD, Anand IS et al (2015) Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail 17(9):925\u2013935. https:\/\/doi.org\/10.1002\/ejhf.327","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"5426_CR13","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545\u20132559. https:\/\/doi.org\/10.1056\/NEJMoa0802743","journal-title":"N Engl J Med"},{"issue":"4","key":"5426_CR14","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.1371\/journal.pbio.0020108","volume":"2","author":"E Bair","year":"2004","unstructured":"Bair E, Tibshirani R (2004) Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2(4):E108. https:\/\/doi.org\/10.1371\/journal.pbio.0020108","journal-title":"PLoS Biol"},{"issue":"2","key":"5426_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Look Ahead Research Group, Wing RR, Bolin P et al (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369(2):145\u2013154. https:\/\/doi.org\/10.1056\/NEJMoa1212914","journal-title":"N Engl J Med"},{"issue":"24","key":"5426_CR16","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"RL Frye","year":"2009","unstructured":"BARI 2D Study Group, Frye RL, August P et al (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360(24):2503\u20132515. https:\/\/doi.org\/10.1056\/NEJMoa0805796","journal-title":"N Engl J Med"},{"issue":"12A","key":"5426_CR17","doi-asserted-by":"publisher","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"Accord Study Group, Buse JB, Bigger JT et al (2007) Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 99(12A):21i\u201333i. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.003","journal-title":"Am J Cardiol"},{"issue":"5","key":"5426_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2337\/dc15-2283","volume":"39","author":"ACCORD Study Group","year":"2016","unstructured":"ACCORD Study Group (2016) Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes. Diabetes Care 39(5):701\u2013708. https:\/\/doi.org\/10.2337\/dc15-2283","journal-title":"Diabetes Care"},{"issue":"5","key":"5426_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/s0197-2456(03)00064-3","volume":"24","author":"DH Ryan","year":"2003","unstructured":"Ryan DH, Espeland MA, Foster GD et al (2003) Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24(5):610\u2013628. https:\/\/doi.org\/10.1016\/s0197-2456(03)00064-3","journal-title":"Control Clin Trials"},{"issue":"1","key":"5426_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, Buhlmann P (2012) MissForest--non-parametric missing value imputation for mixed-type data. Bioinformatics 28(1):112\u2013118. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597","journal-title":"Bioinformatics"},{"key":"5426_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/b97377","volume-title":"Survival analysis: techniques for censored and truncated data","author":"JP Klein","year":"2003","unstructured":"Klein JP, Moeschberger ML (2003) Survival analysis: techniques for censored and truncated data, 2nd edn. Springer, New York","edition":"2"},{"issue":"2","key":"5426_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwarz","year":"1978","unstructured":"Schwarz G (1978) Estimating the dimension of a model. Ann Stat 6(2):461\u2013464. https:\/\/doi.org\/10.1214\/aos\/1176344136","journal-title":"Ann Stat"},{"issue":"1","key":"5426_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/01969727408546059","volume":"4","author":"JC Dunn","year":"1974","unstructured":"Dunn JC (1974) Well-separated clusters and optimal fuzzy partitions. J Cybernetics 4(1):95\u2013104. https:\/\/doi.org\/10.1080\/01969727408546059","journal-title":"J Cybernetics"},{"issue":"25 Pt B","key":"5426_CR24","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G et al (2014) 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B):2935\u20132959. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5426_CR25","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/sim.7606","volume":"37","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Zhou QM, Li B, Cai H, Chow EJ, Armstrong GT (2018) A threshold-free summary index of prediction accuracy for censored time to event data. Stat Med 37(10):1671\u20131681. https:\/\/doi.org\/10.1002\/sim.7606","journal-title":"Stat Med"},{"issue":"10","key":"5426_CR26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.2337\/dc08-0662","volume":"31","author":"J Cederholm","year":"2008","unstructured":"Cederholm J, Eeg-Olofsson K, Eliasson B et al (2008) Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31(10):2038\u20132043. https:\/\/doi.org\/10.2337\/dc08-0662","journal-title":"Diabetes Care"},{"issue":"6","key":"5426_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak 26(6):565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Mak"},{"issue":"1","key":"5426_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104","journal-title":"Educ Psychol Meas"},{"issue":"5","key":"5426_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, Karajamaki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361\u2013369. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"5426_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT (2019) Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol 7(6):442\u2013451. https:\/\/doi.org\/10.1016\/S2213-8587(19)30087-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"311","key":"5426_CR31","doi-asserted-by":"publisher","first-page":"311ra174","DOI":"10.1126\/scitranslmed.aaa9364","volume":"7","author":"L Li","year":"2015","unstructured":"Li L, Cheng WY, Glicksberg BS et al (2015) Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 7(311):311ra174. https:\/\/doi.org\/10.1126\/scitranslmed.aaa9364","journal-title":"Sci Transl Med"},{"key":"5426_CR32","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1080\/03610926.2016.1277753","volume":"46","author":"M Marbac","year":"2017","unstructured":"Marbac M, Biernacki C, Vandewalle V (2017) Model-based clustering of Gaussian copulas for mixed data. Communications in Statistics - Theory and Methods 46:11635\u201311656. https:\/\/doi.org\/10.1080\/03610926.2016.1277753","journal-title":"Communications in Statistics - Theory and Methods"},{"issue":"4","key":"5426_CR33","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11222-016-9670-1","volume":"27","author":"M Marbac","year":"2017","unstructured":"Marbac M, Sedki M (2017) Variable selection for model-based clustering using the integrated complete-data likelihood. Stat Comput 27(4):1049\u20131063. https:\/\/doi.org\/10.1007\/s11222-016-9670-1","journal-title":"Stat Comput"},{"issue":"7","key":"5426_CR34","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/bioinformatics\/bty786","volume":"35","author":"M Marbac","year":"2019","unstructured":"Marbac M, Sedki M (2019) VarSelLCM: an R\/C++ package for variable selection in model-based clustering of mixed-data with missing values. Bioinformatics 35(7):1255\u20131257. https:\/\/doi.org\/10.1093\/bioinformatics\/bty786","journal-title":"Bioinformatics"},{"issue":"23","key":"5426_CR35","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1136\/heartjnl-2014-305657","volume":"100","author":"JR Brownrigg","year":"2014","unstructured":"Brownrigg JR, de Lusignan S, McGovern A et al (2014) Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus. Heart 100(23):1837\u20131843. https:\/\/doi.org\/10.1136\/heartjnl-2014-305657","journal-title":"Heart"},{"issue":"4","key":"5426_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann JF, Yi Q et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286(4):421\u2013426. https:\/\/doi.org\/10.1001\/jama.286.4.421","journal-title":"JAMA"},{"issue":"3","key":"5426_CR37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/dc17-2252","volume":"41","author":"S Basu","year":"2018","unstructured":"Basu S, Raghavan S, Wexler DJ, Berkowitz SA (2018) Characteristics associated with decreased or increased mortality risk from glycemic therapy among patients with type 2 diabetes and high cardiovascular risk: machine learning analysis of the ACCORD trial. Diabetes Care 41(3):604\u2013612. https:\/\/doi.org\/10.2337\/dc17-2252","journal-title":"Diabetes Care"},{"issue":"4","key":"5426_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jchf.2016.11.015","volume":"5","author":"IS Anand","year":"2017","unstructured":"Anand IS, Claggett B, Liu J et al (2017) Interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT trial. JACC Heart Fail 5(4):241\u2013252. https:\/\/doi.org\/10.1016\/j.jchf.2016.11.015","journal-title":"JACC Heart Fail"},{"issue":"15","key":"5426_CR39","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359(15):1577\u20131589. https:\/\/doi.org\/10.1056\/NEJMoa0806470","journal-title":"N Engl J Med"},{"issue":"11","key":"5426_CR40","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","volume":"139","author":"D Fitchett","year":"2019","unstructured":"Fitchett D, Inzucchi SE, Cannon CP et al (2019) Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial. Circulation 139(11):1384\u20131395. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037778","journal-title":"Circulation"},{"issue":"36","key":"5426_CR41","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1093\/eurheartj\/ehaa496","volume":"41","author":"M Serenelli","year":"2020","unstructured":"Serenelli M, Bohm M, Inzucchi SE et al (2020) Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF). Eur Heart J 41(36):3402\u20133418. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa496","journal-title":"Eur Heart J"},{"issue":"1","key":"5426_CR42","doi-asserted-by":"publisher","first-page":"e012797","DOI":"10.1161\/JAHA.119.012797","volume":"9","author":"A Sharma","year":"2020","unstructured":"Sharma A, Vaduganathan M, Ferreira JP et al (2020) Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE trial. J Am Heart Assoc 9(1):e012797. https:\/\/doi.org\/10.1161\/JAHA.119.012797","journal-title":"J Am Heart Assoc"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05426-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T01:02:14Z","timestamp":1647133334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5426"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05426-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}